Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$0.37 USD
-0.01 (-2.37%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.37 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Athira Pharma, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ATHA 0.37 -0.01(-2.37%)
Will ATHA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATHA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATHA
Biotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More
ATHA Stock Tanks as Alzheimer's Study Fails to Meet Primary Goal
ATHA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Athira Pharma (ATHA) This Year?
Other News for ATHA
Athira Pharma GAAP EPS of -$0.18 misses by $0.04
Athira Pharma Inc Reports Q2 2025 EPS of -$0. ...
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update | ATHA ...
Athena Gold Significantly Expands Laird Lake and Excelsior Springs Projects
12 Health Care Stocks Moving In Wednesday's After-Market Session